Press release
Palatin Technologies' UC Treatment Shows Remarkable 78% Clinical Response Rate in Phase 2 Topline Data - Potential Game-Changer for Millions Suffering from Ulcerative Colitis (NYSE: PTN)
Palatin Technologies (NYSE American: PTN)* just unveiled remarkable topline results from its Phase 2 study of PL8177 for ulcerative colitis (UC), demonstrating what could be a disruptive new treatment approach for this debilitating inflammatory bowel condition.
The data seems impressive - an extraordinary 78% of patients treated with PL8177 achieved clinical response compared to just 33% for placebo, with statistical significance (p
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Palatin Technologies' UC Treatment Shows Remarkable 78% Clinical Response Rate in Phase 2 Topline Data - Potential Game-Changer for Millions Suffering from Ulcerative Colitis (NYSE: PTN) here
News-ID: 3947959 • Views: …
More Releases from ABNewswire
VIP Auto PA: Auto Brokers Near Me Redefine Transparent Car Leasing in Feastervil …
VIP Auto PA continues serving Pennsylvania with transparent, factory-direct car leasing services from its Feasterville-Trevose location, offering zero-down options and no-haggle pricing across all vehicle makes and models.
Feasterville-Trevose, PA - The traditional car-buying experience has long frustrated consumers with high-pressure sales tactics and inflated pricing structures. VIP Auto PA [http://www.vipautopa.com/] continues addressing these industry pain points through a customer-centric brokerage model that has served Pennsylvania drivers since 2007. Operating from…
Austin Nail Salon Dream Spa Expands Service Menu with Apres Gel-X and Holistic W …
Dream Spa in Austin expands with Apres Gel-X nails, infrared sauna, and head spa treatments, offering comprehensive beauty and wellness services at its Airport Boulevard location near downtown Austin.
Dream Spa [https://www.dreamspaatx.com/], located at 5301 Airport Blvd, Suite 200 in Austin, Texas, has announced the expansion of its service offerings to include authentic Apres Gel-X nail extensions, infrared sauna therapy, and signature head spa treatments. The locally established business continues to…
Terrance Private Investigator Expands Houston Private Investigator Services with …
Terrance Private Investigator launches a Houston community program offering consultation, family case support, and professional investigation services to residents facing sensitive personal matters.
A Houston-based investigative firm is taking action to support families facing difficult personal situations. Terrance Private Investigator & Associates [https://piterrance.com/] has announced a new community initiative designed to provide accessible resources and confidential case consultations for residents throughout the Houston area.
The program addresses growing concerns among families facing…
El Monte Agency Strengthens Home Insurance Options and Community Protection Serv …
Marvin Martinez: Allstate Insurance strengthens El Monte's insurance options with bilingual services, comprehensive coverage, and community-focused customer education, earning Elite Agent recognition through consistent service excellence.
El Monte, California - The local insurance landscape continues to evolve as Marvin Martinez, of Allstate Insurance [https://agents.allstate.com/marvin-martinez-el-monte-ca.html?utm_source=GMB&utm_medium=Website], reinforces the company's commitment to protecting families and businesses throughout the San Gabriel Valley. The agency's focus on personalized coverage solutions has positioned it as a trusted…
More Releases for Palatin
Moderate Dry Eye Market Growth to Accelerate in Forecast Period (2023-2032), Del …
The Key Moderate Dry Eye Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Moderate Dry Eye market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Moderate Dry Eye pipeline products will significantly revolutionize the Moderate Dry Eye market dynamics.
DelveInsight's "Moderate Dry Eye Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding…
Mild Dry Eye Market Growth Projections 2023-2032: DelveInsight Analysis | Palati …
The Key Mild Dry Eye Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Mild Dry Eye market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Mild Dry Eye pipeline products will significantly revolutionize the Mild Dry Eye market dynamics.
DelveInsight's "Mild Dry Eye Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding…
Dry Eye Disease Market Growth Projections 2024-2034: DelveInsight Analysis | Pal …
The Key Dry Eye Disease Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics.
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding…
Dry Eye Disease Market to Expand Significantly by 2034, States DelveInsight Repo …
The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics.
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Dry Eye Disease, historical and forecasted epidemiology as well as the Dry Eye…
Palatin Technologies' Obesity Drug Receives FDA Orphan Designation; Phase 2 Resu …
Palatin Technologies (NYSE: PTN)* and their latest developments: Palatin's Oral MC4R Agonist Gets FDA Orphan Drug Status; Phase 2 Results in Drug Targeting $44 Billion Obesity Market Expected Any Day According to the Company, alongside results from ulcerative colitis trial; Only Oral Option in Market Currently Dominated by Injections Uniquely Positioning Palatin
In an exciting development for the biopharma market, Palatin Technologies (NYSE: PTN)* announced that it has secured FDA orphan…
Dry Eye Disease Market to Show Incremental Growth, asserts DelveInsight | Promin …
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Dry Eye Disease, historical and forecasted epidemiology as well as the Dry Eye Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Dry Eye Disease market report provides current treatment practices, emerging drugs, Dry Eye Disease market share of the individual therapies, current and forecasted…
